SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (641)5/19/1997 6:11:00 PM
From: biowa   of 9719
 
!Kung,

<<Be vewy qwiet, I'm milking wabbits... Perhaps we can make it the rallying cry of GZTC shareholders?>>

I'll yell it at the next annual meeting if you will ;-)

Seriously, to expand on what I said earlier, transgenic milk production of proteins has enormous advantages over either recombinant prokaryotic or eukaryotic cell culture. However, there is some concern about consistency in results, infection of the host animal, etc. Many of the things which make a living, breathing bioreactor so attractive can make it a nightmare from a quality control standpoint. In addition, there is now work underway on transgenic production in plants of mammalian biomolecules (eventually making the Midwest one big pharma plant :-o), but that is much further down the way.

All this considered, production by lactation will probably be one of the big technologies in the next decade. Now the only question is will GZTC be the leader in this field when revenues start to roll in?

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News